Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ramzi Mohommad
Pan-BCL-2 Inhibitor AT-101 Enhances Tumor Cell Killing by EGFR Targeted T Cells
PLoS ONE
Multidisciplinary
Related publications
LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody–Induced Tumor Cell Killing by Effector CD8+ T Cells
Journal of Immunology
Allergy
Immunology
A DHODH Inhibitor Increases P53 Synthesis and Enhances Tumor Cell Killing by P53 Degradation Blockage
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Inhibition of CHK1 Enhances Cell Death Induced by the BCL-2-Selective Inhibitor ABT-199 in Acute Myeloid Leukemia Cells
Oncotarget
Oncology
Downregulation of BCL-2 Expression in Lymphoma Cells by BCL-2 ARE-targeted Modified, Synthetic Ribozyme
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
At-101, a Small Molecule Inhibitor of Anti-Apoptotic BCL-2 Family Members, Activates the SAPK/JNK Pathway and Enhances Radiation-Induced Apoptosis
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Cancer Vaccines: The Molecular Basis for T Cell Killing of Tumor Cells
Oncologist
Cancer Research
Medicine
Oncology
Pan-BCL-2 Inhibitor Obatoclax Is a Potent Late Stage Autophagy Inhibitor in Colorectal Cancer Cells Independent of Canonical Autophagy Signaling
BMC Cancer
Cancer Research
Oncology
Genetics
The Functional Verification of EGFR-CAR T-Cells Targeted to Hypopharyngeal Squamous Cell Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
A Histone Deacetylase Inhibitor Enhances Killing of Undifferentiated Thyroid Carcinoma Cells by P53 Gene Therapy
Journal of Clinical Endocrinology and Metabolism
Biochemistry
Endocrinology
Clinical Biochemistry
Medicine
Metabolism
Diabetes